Karima Mokhtari
Impact in
- Genetics top 0.02%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Co-authors
- Marc SansonKhê Hoang‐XuanJean‐Yves DelattreAhmed IdbaïhYannick MarieBlandine BoisselierFlorence Laigle–DonadeyFrançois Ducray
- Journals
- Journal of Neuro-Oncology (31 papers)Neuro-Oncology (25 papers)Neurology (18 papers)Journal of Clinical Oncology (10 papers)Brain Pathology (8 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Karima Mokhtari
226 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Genetics 7.2k
- Cancer Research 2.6k
- Neurology 2.4k
- Pulmonary and Respiratory Medicine 2.6k
- Pathology and Forensic Medicine 1.3k
Countries citing papers authored by Karima Mokhtari
This map shows the geographic impact of Karima Mokhtari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karima Mokhtari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karima Mokhtari more than expected).
Fields of papers citing papers by Karima Mokhtari
This network shows the impact of papers produced by Karima Mokhtari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karima Mokhtari. The network helps show where Karima Mokhtari may publish in the future.
Co-authors
The 25 scholars most cited alongside Karima Mokhtari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2022 | 19 | |
| 3 | 2022 | 13 | |
| 4 | 2020 | 10 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 42 | |
| 7 | 2015 | 81 | |
| 8 | 2015 | 41 | |
| 9 | 2014 | 178 | |
| 10 | 2014 | 24 | |
| 11 | 2012 | 24 | |
| 12 | 2011 | 160 | |
| 13 | 2010 | 402 | |
| 14 | Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas Hit paper breakdown → | 2009 | 773 |
| 15 | 2008 | 22 | |
| 16 | 2008 | 132 | |
| 17 | Vers une classification moléculaire des gliomes | 2005 | 6 |
| 18 | 2002 | 21 | |
| 19 | 1999 | 8 | |
| 20 | 1997 | 67 |
About Karima Mokhtari
Karima Mokhtari is a scholar working on Genetics, Neurology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 234 papers that have together received 10.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (155 papers), Meningioma and schwannoma management (38 papers), Brain Metastases and Treatment (36 papers), CNS Lymphoma Diagnosis and Treatment (30 papers), Cancer, Hypoxia, and Metabolism (20 papers), Chromatin Remodeling and Cancer (20 papers), Lymphoma Diagnosis and Treatment (19 papers) and Neurofibromatosis and Schwannoma Cases (17 papers). The work is most often cited by research in Genetics (7.2k citations), Cancer Research (2.6k citations), Neurology (2.4k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Pathology and Forensic Medicine (1.3k citations). Karima Mokhtari has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Marc Sanson, Khê Hoang‐Xuan, Jean‐Yves Delattre, Ahmed Idbaïh, Yannick Marie, Blandine Boisselier, Florence Laigle–Donadey, François Ducray, M. Kujas and Alain Carpentier. Their work appears in journals such as Journal of Neuro-Oncology, Neuro-Oncology, Neurology, Journal of Clinical Oncology and Brain Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.